title: Association of genetic variants at 3q22 with nephropathy in patients with type 1 diabetes mellitus.
abstract: Diabetic nephropathy (DN) is the primary cause of morbidity and mortality in patients with type 1 diabetes mellitus (T1DM) and affects about 30% of these patients. We have previously localized a DN locus on chromosome 3q with suggestive linkage in Finnish individuals. Linkage to this region has also been reported earlier by several other groups. To fine map this locus, we conducted a multistage case-control association study in T1DM patients, comprising 1822 cases with nephropathy and 1874 T1DM patients free of nephropathy, from Finland, Iceland, and the British Isles. At the screening stage, we genotyped 3072 tag SNPs, spanning a 28 Mb region, in 234 patients and 215 controls from Finland. SNPs that met the significance threshold of p < 0.01 at this stage were followed up by a series of sample sets. A genetic variant, rs1866813, in the noncoding region at 3q22 was associated with increased risk of DN (overall p = 7.07 x 10(-6), combined odds ratio [OR] of the allele = 1.33). The estimated genotypic ORs of this variant in all Finnish samples suggested a codominant effect, resulting in significant association, with a p value of 4.7 x 10(-5) (OR = 1.38; 95% confidence interval = 1.18-1.62). Additionally, an 11 kb segment flanked by rs62408925 and rs1866813, two strongly correlated variants (r(2) = 0.95), contains three elements highly conserved across multiple species. Independent replication will clarify the role of the associated variants at 3q22 in influencing the risk of DN.
authors.affiliation: Division of Matrix Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, 171 77 Stockholm, Sweden.
authors.forename: Bing
authors.initials: B
authors.lastname: He
authors.forename: Anne-May
authors.initials: AM
authors.lastname: Osterholm
authors.forename: Anna
authors.initials: A
authors.lastname: Hoverfält
authors.forename: Carol
authors.initials: C
authors.lastname: Forsblom
authors.forename: Eyrún Edda
authors.initials: EE
authors.lastname: Hjörleifsdóttir
authors.forename: Ann-Sofie
authors.initials: AS
authors.lastname: Nilsson
authors.forename: Maikki
authors.initials: M
authors.lastname: Parkkonen
authors.forename: Janne
authors.initials: J
authors.lastname: Pitkäniemi
authors.forename: Astrádur
authors.initials: A
authors.lastname: Hreidarsson
authors.forename: Cinzia
authors.initials: C
authors.lastname: Sarti
authors.forename: Amy Jayne
authors.initials: AJ
authors.lastname: McKnight
authors.forename: A Peter
authors.initials: AP
authors.lastname: Maxwell
authors.forename: Jaakko
authors.initials: J
authors.lastname: Tuomilehto
authors.forename: Per-Henrik
authors.initials: PH
authors.lastname: Groop
authors.forename: Karl
authors.initials: K
authors.lastname: Tryggvason
mesh_terms: D000328:Adult; D000368:Aged; D002893:Chromosomes, Human, Pair 3 / Q000235:genetics*; D003922:Diabetes Mellitus, Type 1 / Q000150:complications / Q000235:genetics*; D003928:Diabetic Nephropathies / Q000150:complications / Q000235:genetics*; D005260:Female; D008040:Genetic Linkage; D020022:Genetic Predisposition to Disease; D014644:Genetic Variation; D006801:Humans; D008297:Male; D008875:Middle Aged; D020641:Polymorphism, Single Nucleotide